Palantir earnings, Pizza Hut's options, a new consumer staples giant and more in Morning Squawk

CEO Alex Karp used the company's earnings call to dismiss his critics, saying, "Enjoy, get some popcorn, they're crying." ...

Kimberly-Clark: Can The Kenvue Acquisition Erase The Decade Of Disappointment?

Kimberly-Clark plans a $48.7B Kenvue acquisition to drive growth and synergies. Learn the deal's risks, impacts, and KMB's ...

The rising threat of cannabis use in pregnancy

Many expectant moms are unaware of the drug’s dangers.

Kimberly-Clark to acquire Tylenol's parent company in nearly $49B deal

Consumer giant Kimberly-Clark has agreed to buy Kenvue, the parent company of embattled brand Tylenol, for nearly $49 billion. But what does this mean for consumers and shareholders?
Channel 3000

Tylenol, Kleenex, Band-Aid and more put under one roof in $48.7 billion consumer brands deal

Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...

These 2 Dividend Kings Are Combining in a $48.7 Billion Megadeal. Is It A Win-Win for Dividend Investors?

The consumer health and wellness giants are both Dividend Kings, with more than 50 years of consecutive annual payout ...
Altoona Mirror

Kimberly-Clark buying Tylenol maker

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark will own about 54% of ...
Tribune Chronicle

Kimberly-Clark plans product expansion

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health ...

Kimberly-Clark buys Tylenol-maker for $40 billion: What it means for your go-to painkiller

Tylenol faces scrutiny over pregnancy use and autism links, despite scientific bodies finding no firm evidence. While ...